Aldosterone: From Essential Tubular Regulator to Pathological Driver—Physiology, Disease, and Therapeutic Advances
International Journal of Molecular Sciences · 10.09.2025 · 26 (18) · 8829
DOI: 10.3390/ijms26188829 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.09.2025. Verfasst von Camillo Tancredi Strizzi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, 00168 Rome, Italy. Hauptthemen laut MEDLINE: Aldosterone. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aldosterone is a key regulator of sodium reabsorption, potassium secretion, and acid–base balance along the aldosterone-sensitive distal nephron (ASDN), where it exerts coordinated, segment-specific control over tubular transport. Although essential for volume conservation in terrestrial environments, aldosterone signaling has become maladaptive in modern sodium-rich contexts, contributing to systemic inflammation, fibrosis, and progression of cardiovascular and kidney disease. This review examines the regulation of aldosterone biosynthesis, the molecular diversity of mineralocorticoid receptor (MR) signaling, and the cellular mechanisms by which aldosterone shapes ion transport in the ASDN. A detailed classification of aldosterone-related disorders is presented, including hyperaldosteronism, pseudo-hyperaldosteronism, aldosterone resistance, and hypoaldosteronism. The therapeutic section focuses on MR overactivation in chronic kidney disease, critically appraising the clinical use of steroidal and non-steroidal MR antagonists. In addition, emerging strategies targeting aldosterone synthesis and downstream inflammatory pathways are discussed as potential approaches to address residual cardiorenal risk and the aldosterone breakthrough phenomenon. Together, these insights support a mechanistic reappraisal of aldosterone as both a physiological modulator and a pathologic driver, with implications for biomarker-guided, targeted therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
- Nephrology, Dialysis and Transplantation Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
- Division of Renal Medicine, Ospedale Isola Tiberina-Gemelli Isola, 00186 Rome, Italy.
ORCID-Profile: Camillo Tancredi Strizzi, Francesco Pesce
Zitieren
APA
Strizzi, C. T., D'Ambrosio, V., Grandaliano, G., & Pesce, F. (2025). Aldosterone: From Essential Tubular Regulator to Pathological Driver—Physiology, Disease, and Therapeutic Advances. International Journal of Molecular Sciences, 26(18), 8829. https://doi.org/10.3390/ijms26188829
Vancouver
Strizzi CT, D'Ambrosio V, Grandaliano G, Pesce F. Aldosterone: From Essential Tubular Regulator to Pathological Driver—Physiology, Disease, and Therapeutic Advances. International Journal of Molecular Sciences. 2025;26(18):8829. doi:10.3390/ijms26188829
BibTeX
@article{Strizzi2025,
author = {Strizzi, Camillo Tancredi and D'Ambrosio, Viola and Grandaliano, Giuseppe and Pesce, Francesco},
title = {Aldosterone: From Essential Tubular Regulator to Pathological Driver—Physiology, Disease, and Therapeutic Advances},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {18},
pages = {8829},
doi = {10.3390/ijms26188829}
}
EUVIMED